Pathophysiology and Treatment of Cheyne-Stokes Respiration Thorax: First Published As 10.1136/Thx.53.6.514 on 1 June 1998

Total Page:16

File Type:pdf, Size:1020Kb

Pathophysiology and Treatment of Cheyne-Stokes Respiration Thorax: First Published As 10.1136/Thx.53.6.514 on 1 June 1998 514 Thorax 1998;53:514–518 Pathophysiology and treatment of Cheyne-Stokes respiration Thorax: first published as 10.1136/thx.53.6.514 on 1 June 1998. Downloaded from M T Naughton Cheyne-Stokes respiration is a disorder charac- results from hyperventilation, prolonged circu- terised by recurrent central apnoeas during lation time, and reduced blood gas buVering sleep alternating with a crescendo-decrescendo capacity.21 pattern of tidal volume.12 It is often observed in patients with congestive heart failure, usually HYPERVENTILATION during stages 1 and 2 non-REM sleep when Hyperventilation, the common pathophysi- ventilation is under chemical-metabolic ological feature of all forms of periodic breath- 2 control. Patients with Cheyne-Stokes respira- ing, causes PaCO2 levels to fall below the tion usually present with the symptoms of apnoeic threshold triggering a central apnoea. orthopnoea, paroxysmal nocturnal dyspnoea, Once the peripheral chemoreceptors sense an excessive daytime sleepiness and witnessed apnoea related rise in the PaCO2 level above the apnoeas in the setting of congestive heart apnoea threshold, hyperventilation recurs driv- 13 failure. Excessive weight and snoring may be ing the PaCO2 level below the apnoea threshold absent. Approximately 50% of patients with once again.2 symptomatic congestive heart failure have Increased central hypercapnic ventilatory sleep apnoea, mainly of the Cheyne-Stokes responsiveness has been reported to occur in respiration variety.4-6 As congestive heart failure Cheyne-Stokes respiration with congestive occurs in 1% of the adult population and dou- heart failure22 and in other forms of periodic bles in prevalence for each decade beyond 60 breathing in subjects without congestive heart years,7 Cheyne-Stokes respiration is common failure—namely, idiopathic non-hypercapnic but often left unrecognised. central sleep apnoea23 and high altitude peri- odic breathing.24 25 A significant positive corre- Adverse eVects lation between central hypercapnic ventilatory Based upon small case series, patients with responsiveness and percentage sleep time with congestive heart failure and Cheyne-Stokes Cheyne-Stokes respiration has also been 26 respiration have a significantly greater reported. Taken together, it would appear http://thorax.bmj.com/ mortality,89 particularly if present during that Cheyne-Stokes respiration is associated wakefulness,10 than those without Cheyne- with increased central chemosensitivity and Stokes respiration. Although Cheyne-Stokes explains the low mean PaCO2 observed during respiration is likely to arise as a result of sleep and wakefulness in patients with Cheyne- congestive heart failure, once present it is likely Stokes respiration.32728As the response time of to have adverse eVects upon cardiac function central chemoreceptors in normal subjects is of akin to a vicious cycle. Following an initial car- the magnitude of five minutes29 and the mean diac insult there is a compensatory increase in cycle length of Cheyne-Stokes respiration is 60 11 12 32830 sympathetic activity which in susceptible seconds, rapidly responsive peripheral on September 25, 2021 by guest. Protected copyright. patients causes hyperventilation,13 destabilises chemoreceptors are likely to play an integral respiratory control, and leads to Cheyne- part in the propagation of Cheyne-Stokes Stokes respiration. Once Cheyne-Stokes respi- respiration.29 Data in support of a significant ration is established, apnoea related hypoxae- positive relationship between increased periph- mia causes cardiac diastolic dysfunction.14 eral chemosensitivity and periodic breathing, Hypoxaemia and arousals lead to further however, are limited to idiopathic non- increases in sympathetic activity15 which con- hypercapnic central sleep apnoea23 and high tribute to potentially fatal arrhythmias16-18 and altitude periodic breathing.24 25 further cardiotoxicity.19 It is likely that one or more of the following Hyperventilation and resultant increased factors are likely to contribute to hyperventila- work of the respiratory muscles probably play a tion in congestive heart failure. part in the symptom of paroxysmal nocturnal dyspnoea1 and place an increased demand Hypoxaemia upon the already reduced cardiac output.20 Hypoxaemia may contribute to hyperventila- Finally, patients with congestive heart failure tion and Cheyne-Stokes respiration in conges- Alfred Sleep Disorders and Cheyne-Stokes respiration frequently tive heart failure through peripheral chemore- and Ventilatory Failure complain of fatigue and excessive daytime ceptor stimulation. However, in contrast to Service, Department of Respiratory sleepiness which relate to reduced amounts of high altitude periodic breathing where hypo- Medicine, Alfred total, slow wave, and REM sleep in association baric hypoxia stimulation of the peripheral Hospital, Commercial with marked sleep fragmentation due to arous- chemoreceptors is likely to be responsible for Road, Prahran 3181, als from sleep.5 the periodic breathing,24 hypoxia is thought not Victoria, Australia to be solely responsible for the development of M T Naughton Pathophysiology Cheyne-Stokes respiration in patients with Correspondence to: Instability of respiratory control underpins the congestive heart failure for the following Dr M T Naughton. development of Cheyne-Stokes respiration and reasons. Hyperventilation, in the absence of Pathophysiology and treatment of Cheyne-Stokes respiration 515 hypoxaemia, has been shown to trigger central is directly related to the length of the apnoeas during non-REM sleep induced by apnoea-hyperpnoea cycle and contributes to either mechanical hyperventilation in normal the crescendo-decrescendo respiratory Thorax: first published as 10.1136/thx.53.6.514 on 1 June 1998. Downloaded from subjects31 or by arousal induced hyperventila- pattern.28 30 tion in Cheyne-Stokes respiration3 and idi- opathic non-hypercapnic central sleep apnoea.32 Furthermore, supplemental oxygen REDUCED BLOOD GAS BUFFERING CAPACITY Reduced total body oxygen and carbon dioxide has been shown to attenuate rather than stores are considered factors that amplify the abolish Cheyne-Stokes respiration in patients blood gas oscillations in Cheyne-Stokes respi- with congestive heart failure.33-36 ration. Pulmonary function tests of patients with severe congestive heart failure reveal a Increased pulmonary vagal aVerent traYc restrictive ventilatory defect, and therefore Increased pulmonary vagal aVerent nerve traf- oxygen storage, which relate to cardiomegaly fic related to pulmonary venous congestion and and pleural e usions.44-46 Carbon monoxide pulmonary C fibre stimulation has been shown V transfer capacity is approximately 70% of pre- to induce rapid shallow breathing and hyper- dicted normal values in patients with severe ventilation in animal studies.37-40 In humans congestive heart failure and correlates inversely with congestive heart failure, those with with PCWP.46 Despite these findings, no Cheyne-Stokes respiration have a significantly significant di erences in pulmonary function greater pulmonary artery pressure (mean 34 V tests have been observed between those with mm Hg) than those without Cheyne-Stokes and without Cheyne-Stokes respiration.3927As respiration (mean 21 mm Hg).6 Moreover, patients with Cheyne-Stokes respiration hyper- there is a significant inverse correlation be- ventilate awake and asleep,327 total body tween awake pulmonary capillary wedge pres- 6 carbon dioxide stores are likely to be reduced, sure (PCWP) and awake PaCO . Finally, there 2 hence the carbon dioxide bu ering capacity is a tendency for the analogous condition high V will be diminished. altitude periodic breathing to occur in patients with associated high altitude pulmonary oedema,41 so Cheyne-Stokes respiration with congestive heart failure is associated with Treatment increased pulmonary artery pressures, but Generally, patients with Cheyne-Stokes respi- whether this is a cause and e ect relationship V ration suYcient to cause symptoms have more remains to be seen. than 20 apnoeas and hypopnoeas per hour sleep and should be considered for treatment.5 Increased sympathetic activity Treatment options can be broadly divided into Heistad et al reported a 20% increase in minute five groups: intensive heart failure treatment, http://thorax.bmj.com/ ventilation 10 minutes after a six minute respiratory stimulants, respiratory depressants, venous infusion of noradrenaline, an eVect that oxygen, and continuous positive airway pres- could be blocked by prior treatment with sure (CPAP). propranolol.13 As increased circulating nor- adrenaline levels and hyperventilation occur in congestive heart failure,11 12 particularly in INTENSIVE HEART FAILURE TREATMENT those with Cheyne-Stokes respiration, it is pos- Although it would seem prudent to ensure that sible that peripheral chemoreceptors bathed in patients with Cheyne-Stokes respiration are noradrenaline, or possibly central sympathetic on optimal medical treatment for congestive on September 25, 2021 by guest. Protected copyright. activation related to spontaneous arousals, pre- heart failure, and as a result the severity of cipitates Cheyne-Stokes respiration. Upper Cheyne-Stokes respiration would diminish, airway collapse towards the end of the central there are only limited supportive data. In apnoea, known to occur in Cheyne-Stokes patients with congestive heart failure a raised respiration,42 may also cause arousal from sleep PCWP is associated with greater mortality.47 and
Recommended publications
  • Approach to Cyanosis in a Neonate.Pdf
    PedsCases Podcast Scripts This podcast can be accessed at www.pedscases.com, Apple Podcasting, Spotify, or your favourite podcasting app. Approach to Cyanosis in a Neonate Developed by Michelle Fric and Dr. Georgeta Apostol for PedsCases.com. June 29, 2020 Introduction Hello, and welcome to this pedscases podcast on an approach to cyanosis in a neonate. My name is Michelle Fric and I am a fourth-year medical student at the University of Alberta. This podcast was made in collaboration with Dr. Georgeta Apostol, a general pediatrician at the Royal Alexandra Hospital Pediatrics Clinic in Edmonton, Alberta. Cyanosis refers to a bluish discoloration of the skin or mucous membranes and is a common finding in newborns. It is a clinical manifestation of the desaturation of arterial or capillary blood and may indicate serious hemodynamic instability. It is important to have an approach to cyanosis, as it can be your only sign of a life-threatening illness. The goal of this podcast is to develop this approach to a cyanotic newborn with a focus on these can’t miss diagnoses. After listening to this podcast, the learner should be able to: 1. Define cyanosis 2. Assess and recognize a cyanotic infant 3. Develop a differential diagnosis 4. Identify immediate investigations and management for a cyanotic infant Background Cyanosis can be further broken down into peripheral and central cyanosis. It is important to distinguish these as it can help you to formulate a differential diagnosis and identify cases that are life-threatening. Peripheral cyanosis affects the distal extremities resulting in blue color of the hands and feet, while the rest of the body remains pinkish and well perfused.
    [Show full text]
  • Asphyxia Neonatorum
    CLINICAL REVIEW Asphyxia Neonatorum Raul C. Banagale, MD, and Steven M. Donn, MD Ann Arbor, Michigan Various biochemical and structural changes affecting the newborn’s well­ being develop as a result of perinatal asphyxia. Central nervous system ab­ normalities are frequent complications with high mortality and morbidity. Cardiac compromise may lead to dysrhythmias and cardiogenic shock. Coagulopathy in the form of disseminated intravascular coagulation or mas­ sive pulmonary hemorrhage are potentially lethal complications. Necrotizing enterocolitis, acute renal failure, and endocrine problems affecting fluid elec­ trolyte balance are likely to occur. Even the adrenal glands and pancreas are vulnerable to perinatal oxygen deprivation. The best form of management appears to be anticipation, early identification, and prevention of potential obstetrical-neonatal problems. Every effort should be made to carry out ef­ fective resuscitation measures on the depressed infant at the time of delivery. erinatal asphyxia produces a wide diversity of in­ molecules brought into the alveoli inadequately com­ Pjury in the newborn. Severe birth asphyxia, evi­ pensate for the uptake by the blood, causing decreases denced by Apgar scores of three or less at one minute, in alveolar oxygen pressure (P02), arterial P02 (Pa02) develops not only in the preterm but also in the term and arterial oxygen saturation. Correspondingly, arte­ and post-term infant. The knowledge encompassing rial carbon dioxide pressure (PaC02) rises because the the causes, detection, diagnosis, and management of insufficient ventilation cannot expel the volume of the clinical entities resulting from perinatal oxygen carbon dioxide that is added to the alveoli by the pul­ deprivation has been further enriched by investigators monary capillary blood.
    [Show full text]
  • Clinical Management of Severe Acute Respiratory Infections When Novel Coronavirus Is Suspected: What to Do and What Not to Do
    INTERIM GUIDANCE DOCUMENT Clinical management of severe acute respiratory infections when novel coronavirus is suspected: What to do and what not to do Introduction 2 Section 1. Early recognition and management 3 Section 2. Management of severe respiratory distress, hypoxemia and ARDS 6 Section 3. Management of septic shock 8 Section 4. Prevention of complications 9 References 10 Acknowledgements 12 Introduction The emergence of novel coronavirus in 2012 (see http://www.who.int/csr/disease/coronavirus_infections/en/index. html for the latest updates) has presented challenges for clinical management. Pneumonia has been the most common clinical presentation; five patients developed Acute Respira- tory Distress Syndrome (ARDS). Renal failure, pericarditis and disseminated intravascular coagulation (DIC) have also occurred. Our knowledge of the clinical features of coronavirus infection is limited and no virus-specific preven- tion or treatment (e.g. vaccine or antiviral drugs) is available. Thus, this interim guidance document aims to help clinicians with supportive management of patients who have acute respiratory failure and septic shock as a consequence of severe infection. Because other complications have been seen (renal failure, pericarditis, DIC, as above) clinicians should monitor for the development of these and other complications of severe infection and treat them according to local management guidelines. As all confirmed cases reported to date have occurred in adults, this document focuses on the care of adolescents and adults. Paediatric considerations will be added later. This document will be updated as more information becomes available and after the revised Surviving Sepsis Campaign Guidelines are published later this year (1). This document is for clinicians taking care of critically ill patients with severe acute respiratory infec- tion (SARI).
    [Show full text]
  • Respiratory and Gastrointestinal Involvement in Birth Asphyxia
    Academic Journal of Pediatrics & Neonatology ISSN 2474-7521 Research Article Acad J Ped Neonatol Volume 6 Issue 4 - May 2018 Copyright © All rights are reserved by Dr Rohit Vohra DOI: 10.19080/AJPN.2018.06.555751 Respiratory and Gastrointestinal Involvement in Birth Asphyxia Rohit Vohra1*, Vivek Singh2, Minakshi Bansal3 and Divyank Pathak4 1Senior resident, Sir Ganga Ram Hospital, India 2Junior Resident, Pravara Institute of Medical Sciences, India 3Fellow pediatrichematology, Sir Ganga Ram Hospital, India 4Resident, Pravara Institute of Medical Sciences, India Submission: December 01, 2017; Published: May 14, 2018 *Corresponding author: Dr Rohit Vohra, Senior resident, Sir Ganga Ram Hospital, 22/2A Tilaknagar, New Delhi-110018, India, Tel: 9717995787; Email: Abstract Background: The healthy fetus or newborn is equipped with a range of adaptive, strategies to reduce overall oxygen consumption and protect vital organs such as the heart and brain during asphyxia. Acute injury occurs when the severity of asphyxia exceeds the capacity of the system to maintain cellular metabolism within vulnerable regions. Impairment in oxygen delivery damage all organ system including pulmonary and gastrointestinal tract. The pulmonary effects of asphyxia include increased pulmonary vascular resistance, pulmonary hemorrhage, pulmonary edema secondary to cardiac failure, and possibly failure of surfactant production with secondary hyaline membrane disease (acute respiratory distress syndrome).Gastrointestinal damage might include injury to the bowel wall, which can be mucosal or full thickness and even involve perforation Material and methods: This is a prospective observational hospital based study carried out on 152 asphyxiated neonates admitted in NICU of Rural Medical College of Pravara Institute of Medical Sciences, Loni, Ahmednagar, Maharashtra from September 2013 to August 2015.
    [Show full text]
  • Chronic Hypoxemia in the Newborn Lamb: Cardiovascular, Hematopoietic, and Growth Adaptations
    003 1-3998/85/19 10-l004$02.00/0 PEDIATRIC RESEARCH Val. 19, No. 10, 1985 Copyright O 1985 International Pediatric Research Foundation, Inc. Printed in U.S. A. Chronic Hypoxemia in the Newborn Lamb: Cardiovascular, Hematopoietic, and Growth Adaptations DAVID TEITEL, DANIEL SIDI,' DANIEL BERNSTEIN, MICHAEL A. HEYMANN, AND ABRAHAM M. RUDOLPH Cardiovascular Research Institute and the Departments of Pediatrics, Physiology, and Obstetrics, Gynecology and Reproductive Sciences, University of California, Sun Francisco, California 94143 ABSTRAm. We have created a model of chronic hypox- developed a model of a common cyanotic heart lesion to assess emia in the newborn lamb by decreasing pulmonary blood some of its cardiovascular and metabolic effects on the newborn flow in the presence of an atrial septal defect. Via a left lamb. lateral thoracotomy, we place an inflatable balloon around Several authors have studied acute hypoxemia in the devel- the pulmonary artery and perform an atrial septostomy oping organism and elucidated its effects on general cardiovas- under direct vision. We also insert several vascular cathe- cular function (1-3), regional blood flow (1, 4, 5), metabolic ters and place an electromagnetic flow transducer around activity (6, 7), and course of decompensation (1). The effects of the ascending aorta. Three days after surgery, we inflated sympathetic blockade (8, 9) and decreasing Hb oxygen affinity the balloon in 11 lambs such that arterial oxygen saturation (10, 11) on the response to acute hypoxemia have also been decreased to 60 to 75%. Studies were performed on these addressed. Few studies have been performed on the chronically lambs twice weekly and weekly on 12 normoxemic lambs.
    [Show full text]
  • Respiratory Failure Diagnosis Coding
    RESPIRATORY FAILURE DIAGNOSIS CODING Action Plans are designed to cover topic areas that impact coding, have been the frequent source of errors by coders and usually affect DRG assignments. They are meant to expand your learning, clinical and coding knowledge base. INTRODUCTION Please refer to the reading assignments below. You may wish to print this document. You can use your encoder to read the Coding Clinics and/or bookmark those you find helpful. Be sure to read all of the information provided in the links. You are required to take a quiz after reading the assigned documents, clinical information and the Coding Clinic information below. The quiz will test you on clinical information, coding scenarios and sequencing rules. Watch this video on basics of “What is respiration?” https://www.youtube.com/watch?v=hc1YtXc_84A (3:28) WHAT IS RESPIRATORY FAILURE? Acute respiratory failure (ARF) is a respiratory dysfunction resulting in abnormalities of tissue oxygenation or carbon dioxide elimination that is severe enough to threaten and impair vital organ functions. There are many causes of acute respiratory failure to include acute exacerbation of COPD, CHF, asthma, pneumonia, pneumothorax, pulmonary embolus, trauma to the chest, drug or alcohol overdose, myocardial infarction and neuromuscular disorders. The photo on the next page can be accessed at the link. This link also has complete information on respiratory failure. Please read the information contained on this website link by NIH. 1 http://www.nhlbi.nih.gov/health/health-topics/topics/rf/causes.html
    [Show full text]
  • The Pathophysiology of 'Happy' Hypoxemia in COVID-19
    Dhont et al. Respiratory Research (2020) 21:198 https://doi.org/10.1186/s12931-020-01462-5 REVIEW Open Access The pathophysiology of ‘happy’ hypoxemia in COVID-19 Sebastiaan Dhont1* , Eric Derom1,2, Eva Van Braeckel1,2, Pieter Depuydt1,3 and Bart N. Lambrecht1,2,4 Abstract The novel coronavirus disease 2019 (COVID-19) pandemic is a global crisis, challenging healthcare systems worldwide. Many patients present with a remarkable disconnect in rest between profound hypoxemia yet without proportional signs of respiratory distress (i.e. happy hypoxemia) and rapid deterioration can occur. This particular clinical presentation in COVID-19 patients contrasts with the experience of physicians usually treating critically ill patients in respiratory failure and ensuring timely referral to the intensive care unit can, therefore, be challenging. A thorough understanding of the pathophysiological determinants of respiratory drive and hypoxemia may promote a more complete comprehension of a patient’sclinical presentation and management. Preserved oxygen saturation despite low partial pressure of oxygen in arterial blood samples occur, due to leftward shift of the oxyhemoglobin dissociation curve induced by hypoxemia-driven hyperventilation as well as possible direct viral interactions with hemoglobin. Ventilation-perfusion mismatch, ranging from shunts to alveolar dead space ventilation, is the central hallmark and offers various therapeutic targets. Keywords: COVID-19, SARS-CoV-2, Respiratory failure, Hypoxemia, Dyspnea, Gas exchange Take home message COVID-19, little is known about its impact on lung This review describes the pathophysiological abnormal- pathophysiology. COVID-19 has a wide spectrum of ities in COVID-19 that might explain the disconnect be- clinical severity, data classifies cases as mild (81%), se- tween the severity of hypoxemia and the relatively mild vere (14%), or critical (5%) [1–3].
    [Show full text]
  • Long-Lasting Effect of Prolonged Hypoxemia After Birth on the Immediate Ventilatory Response to Changes in Arterial Partial Pressure of Oxygen in Young Lambs1
    003 1-3998/93/3406-082 1 $03.00/0 PEDIATRIC RESEARCH Vol. 34. No. 6. 1993 Copyright O 1993 International Pediatric Research Foundation. Inc. Printed in U.S.A. Long-Lasting Effect of Prolonged Hypoxemia after Birth on the Immediate Ventilatory Response to Changes in Arterial Partial Pressure of Oxygen in Young Lambs1 Deparrrnenrs of Pediarrics and Prevenrive Medicine, Vanderbilr University School of Medicine. Nashville, Tennessee 37232-2585 ABSTRACT. The effect of prolonged hypoxemia (H) after The immediate ventilatory response to hypoxia and hyperoxia birth on the evolution of the ventilatory response to changes is principally mediated by the peripheral chemoreceptors located in arterial partial pressure of 02was determined in un- in the CB (1-3). The magnitude of this response is proportional anesthetized, awake lambs. H was induced for 12 d after to the strength of 02-sensitive chemoreceptors and is abolished birth in seven lambs through exposure to 0.10 fraction of inspired O2 (Fi02). Five control (C) lambs were kept in by CB denervation (2-4). The role of CB in the ventilatory 0.21 Fi02.The ventilatory response (percent increase from regulation in utero, at the time of relative hypoxemia and hyper- baseline) to acute hypoxia was tested with 0.14 FiOl and capnia, still remains unresolved and controversial (5, 6). Recent 0.10 Fi02. The tonic activity of the peripheral chemore- studies have indicated that the peripheral chemoreceptors are ceptors was assessed by the transient pure oxygen inhala- responsive to changes in oxygen tension during fetal life (7-9), tion test (Dejours' test). The occlusion technique was used although the respiratory response to hypoxemia in the fetus is to measure the baseline neuromuscular drive of breathing.
    [Show full text]
  • CASE REPORT Persistent Hiccups As a Rare Presenting
    UC Irvine Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health Title Persistent Hiccups as a Rare Presenting Symptom of Pulmonary Embolism Permalink https://escholarship.org/uc/item/6mn9685q Journal Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 13(6) ISSN 1936-900X Authors Hassen, Getaw worku Singh, Mona Milkha Kalantari, Hossein et al. Publication Date 2012 DOI 10.5811/westjem.2012.4.6894 License https://creativecommons.org/licenses/by-nc/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California CASE REPORT Persistent Hiccups as a Rare Presenting Symptom of Pulmonary Embolism Getaw worku Hassen, MD, PhD New York Medical College, Metropolitan Hospital Center, Department of Emergency Mona Milkha Singh, MD Medicine, Westchester County, New York Hossein Kalantari, MD Selamawit Yemane-Merriwether, MD Steven Ferrante, PA Ronald Shaw, MD Supervising Section Editor: Rick A. McPheeters, DO Submission history: Submitted September 13, 2011; Revision received March 23, 2012; Accepted April 2, 2012 Full text available through open access at http://escholarship.org/uc/uciem_westjem DOI: 10.5811/westjem.2012.4.6894 Pulmonary embolism (PE) is a life-threatening condition that may present as dyspnea, chest pain, cough or hemoptysis, but often occurs without symptoms. It is not typically associated with hiccups. Hiccups are generally self-limiting benign contractions of the diaphragm that may be associated with medications or food but may also be symptomatic of serious disease when persistent. We report 3 cases of PE presenting as persistent hiccups. [West J Emerg Med. 2012;13(6):479-483] INTRODUCTION esophagitis, gastric volvulus) and cardiac conditions Pulmonary embolism (PE) is a potentially lethal (myocardial infarction, pacemaker lead injury).7, 9, 12, 14-17 condition that can be difficult to diagnose.
    [Show full text]
  • This Poster I It's Designed Large the Placeho Formatted Fo Placeholder
    IS IT TIME TO TAKE THE “O” OUT OF “M.O.N.A.”? UNIVERSITY OF MARYLAND BALTIMORE WASHINGTON MEDICAL CENTER GLEN BURNIE, MD Printing: Felicia Caughlin, RN, Cassie Johnson, RN, & Asisat Popoola, RN This poster is 48” wide by 36” high. It’s designed to be printed on a PURPOSE METHODS RECOMMENDATIONS large To assess the use of supplemental oxygen during a Databases: Cochrane Review, CINAHL, Medline myocardial infarction in patients with oxygen Apply oxygen based on patient saturation above 95% without supplemental Search terms: Oxygen toxicity, acute coronary syndrome, chest pain management, myocardial infarction, oxygen, oxygen saturation. oxygen. cost of oxygen usage Customizing the Content: . Current UM BWMC guideline is to place The placeholders in this Limits: Less than 5 years since publication, randomized monitored patients experience chest pain on 4L controlled studies, systematic reviews BACKGROUND of supplemental oxygen (2L for COPD formatted for you. patients). All evidence was appraised using the Johns Hopkins placeholders to add text, or click According to UMBWMC’s current Chest Pain Nursing Evidence-Based Practice appraisal tools. There is no benefit of supplemental oxygen in an icon to add a table, chart, Management of the Monitored Patient normoxemic (O2Saturation >95%) patients. guidelines, the RN is to apply oxygen in the RESULTS SmartArt graphic, picture or event of a myocardial infarction regardless of multimedia file. patient oxygen saturation Study Level of Evidence Results Limitations Implement guideline change. Cabello et Level 1A No clear effect of oxygen on Three studies reviewed had . UMMS U web-based and in-service training al, 2016 Systematic Review infarct size.
    [Show full text]
  • Guidance for the Distribution of Pulse Oximeters to Patients at Increased Risk for Severe COVID-19
    Guidance for the Distribution of Pulse Oximeters to Patients at Increased Risk for Severe COVID-19 The New York City Department of Health and Mental Hygiene (NYC Health Department) will facilitate the distribution of pulse oximeters to hospitals and outpatient providers that predominantly serve populations disproportionately impacted by COVID-19, including those with medical comorbidities and sociodemographic factors that put them at increased risk for poor outcomes. This document provides guidance for the use of home pulse oximetry to facilitate enhanced home monitoring of patients who are at higher risk for moderate to severe COVID-19 illness. Background Although most cases of COVID-19 are mild, the clinical status of some patients can deteriorate rapidly, particularly in the second week of illness. There are also reports of COVID-19 patients who develop silent hypoxemia, when blood oxygen saturation levels are exceedingly low despite patients not exhibiting shortness of breath or other symptoms of respiratory distress, leading to dangerous delays in care. Risk factors for this specific clinical course have not yet been identified, but providers can take steps to identify a clinical decline promptly so care can be escalated early. Home self-monitoring of peripheral pulse oxygen saturation (SpO2) can be a useful tool to support the ongoing evaluation and care of individuals exhibiting COVID-19 symptoms that are at 1 increased risk for severe illness. In a NorthShore University Health System study,0F 50% of patients discharged with pulse oximeters returned to the emergency department when SpO2 was found to be below 92% (per clinical instructions). These patients were admitted even though they did not perceive their symptoms to be worse.
    [Show full text]
  • 1 Pediatric Pulmonary Puzzlers Physical Examination
    Pediatric pulmonary puzzlers Bruce K. Rubin MEngr, MD, MBA, FAARC Jessie Ball duPont Professor and Chairman, Pediatrics Physician in Chief Children’s Hospital of Richmond Virginia Commonwealth University School of Medicine [1] Noisy breathing in a baby A three month old baby comes to well child check with noisy breathing “since birth” He is feeding vigorously with no choking or excessive spitting up and no respiratory distress with feeding. He has hiccups often No history of pneumonia or otitis media Physical Examination Height and weight 50% for age. Not hypoxemic. Happy baby HEENT: Normal including intact palate by palpation. No head bobbing Neck: No masses Chest: No deformity or retractions Lungs: bilaterally equal air entry with coarse breath sounds and loud inspiratory stridor, no wheezes Investigations? 1 Laryngomalacia Most common cause of chronic stridor in infancy - 60-75% Prolapse of epiglottis or arytenoids into glottis causes upper airway obstruction Should NOT be confused with tracheomalacia Occasionally there is slow maturation of other cartilage May occurs as part of cartilage dysplasia syndrome Laryngomalacia Sometimes there is a family history Coexisting GE reflux is common and due to air swallowing Air swallowing also causes hiccups, flatulence, and abdominal distention Tend to be vigorous feeders and grow well Stridor improves in prone position 2 Laryngomalacia Time Course: Usually begins after 2-4 weeks Significant improvement by 1 year Mild symptoms persist for 2-4 years Need for surgical intervention determined by
    [Show full text]